Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;48(3):2669-2686.
doi: 10.1007/s11033-021-06237-9. Epub 2021 Mar 1.

Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes

Mahdi Rizk #  1 , Zahraa Saker #  1 , Hayat Harati  1 , Youssef Fares  1   2 , Hisham F Bahmad #  3 , Sanaa Nabha #  4
Affiliations
Review

Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes

Mahdi Rizk et al. Mol Biol Rep. 2021 Mar.

Abstract

Autism spectrum disorder (ASD) is a complex and multifactorial neurodevelopmental disorder characterized by the presence of restricted interests and repetitive behaviors besides deficits in social communication. Syndromic ASD is a subset of ASD caused by underlying genetic disorders, most commonly Fragile X Syndrome (FXS) and Rett Syndrome (RTT). Various mutations and consequent malfunctions in core signaling pathways have been identified in ASD, including glycogen synthase kinase 3 (GSK3). A growing body of evidence suggests a key role of GSK3 dysregulation in the pathogenesis of ASD and its related disorders. Here, we provide a synopsis of the implication of GSK3 in ASD, FXS, and RTT as a promising therapeutic target for the treatment of ASD.

Keywords: Autism spectrum disorder; Fragile X syndrome; Glycogen synthase kinase 3; Rett syndrome.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcin C, Montiel-Nava C, Patel V, Paula CS, Wang C, Yasamy MT, Fombonne E (2012) Global prevalence of autism and other pervasive developmental disorders. Autism Res 5(3):160–179. https://doi.org/10.1002/aur.239 - DOI - PubMed - PMC
    1. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Association Publishing. https://doi.org/10.1176/appi.books.9780890425596 - DOI
    1. Persico AM, Napolioni V (2013) Autism genetics. Behav Brain Res 251:95–112. https://doi.org/10.1016/j.bbr.2013.06.012 - DOI - PubMed
    1. Lai M-C, Lombardo MV, Baron-Cohen S (2014) Autism. Lancet 383(9920):896–910. https://doi.org/10.1016/s0140-6736(13)61539-1 - DOI - PubMed
    1. Hur E-M, Zhou F-Q (2010) GSK3 signalling in neural development. Nat Rev Neurosci 11(8):539–551. https://doi.org/10.1038/nrn2870 - DOI - PubMed - PMC

MeSH terms

Substances